DNA-methylation-mediated silencing of miR-486-5p promotes colorectal cancer proliferation and migration through activation of PLAGL2/IGF2/β-catenin signal pathways

[1]  Liang Wu,et al.  MicroRNA-664 Targets Insulin Receptor Substrate 1 to Suppress Cell Proliferation and Invasion in Breast Cancer. , 2019, Oncology research.

[2]  Lihua Jiang,et al.  MicroRNA-623 Targets Cyclin D1 to Inhibit Cell Proliferation and Enhance the Chemosensitivity of Cells to 5-Fluorouracil in Gastric Cancer. , 2018, Oncology research.

[3]  Kai Yuan,et al.  miR-486-5p functions as an oncogene by targeting PTEN in non-small cell lung cancer. , 2018, Pathology, research and practice.

[4]  Chunxing Yang,et al.  Studying the mechanism of PLAGL2 overexpression and its carcinogenic characteristics based on 3′-untranslated region in colorectal cancer , 2018, International journal of oncology.

[5]  W. Zhai,et al.  DNA‐methylation‐mediated repression of miR‐766‐3p promotes cell proliferation via targeting SF2 expression in renal cell carcinoma , 2017, International journal of cancer.

[6]  Yang Yang,et al.  The miR-486-5p plays a causative role in prostate cancer through negative regulation of multiple tumor suppressor pathways , 2017, Oncotarget.

[7]  G. Qing,et al.  Epigenetic silencing of microRNA-137 enhances ASCT2 expression and tumor glutamine metabolism , 2017, Oncogenesis.

[8]  Zengfang Wang,et al.  Exosome-encapsulated microRNAs as circulating biomarkers for colorectal cancer , 2017, Oncotarget.

[9]  Yusuke Nakamura,et al.  miR-196b, miR-378a and miR-486 are predictive biomarkers for the efficacy of vaccine treatment in colorectal cancer , 2017, Oncology letters.

[10]  Zhi Zhu,et al.  Pleomorphic adenoma gene like-2 induces epithelial-mesenchymal transition via Wnt/β-catenin signaling pathway in human colorectal adenocarcinoma , 2017, Oncology reports.

[11]  Jiwei Sun,et al.  RETRACTED ARTICLE: MiR-200 suppresses metastases of colorectal cancer through ZEB1 , 2016, Tumor Biology.

[12]  X. Yu,et al.  Downregulated miR-486-5p acts as a tumor suppressor in esophageal squamous cell carcinoma. , 2016, Experimental and therapeutic medicine.

[13]  A. Weisz,et al.  The RNA-Binding Protein SYNCRIP Is a Component of the Hepatocyte Exosomal Machinery Controlling MicroRNA Sorting. , 2016, Cell reports.

[14]  Liang Zhao,et al.  Epigenetic silencing of miR-490-3p promotes development of an aggressive colorectal cancer phenotype through activation of the Wnt/β-catenin signaling pathway. , 2016, Cancer letters.

[15]  Ning Shi,et al.  miR-486-5p attenuates tumor growth and lymphangiogenesis by targeting neuropilin-2 in colorectal carcinoma , 2016, OncoTargets and therapy.

[16]  Li Zhang,et al.  miR-486-5p inhibits cell growth of papillary thyroid carcinoma by targeting fibrillin-1. , 2016, Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie.

[17]  Thomas Bonfert,et al.  p53-Regulated Networks of Protein, mRNA, miRNA, and lncRNA Expression Revealed by Integrated Pulsed Stable Isotope Labeling With Amino Acids in Cell Culture (pSILAC) and Next Generation Sequencing (NGS) Analyses* , 2015, Molecular & Cellular Proteomics.

[18]  H. Brody.  Colorectal cancer , 2015, Nature.

[19]  C. Mathers,et al.  Cancer incidence and mortality worldwide: Sources, methods and major patterns in GLOBOCAN 2012 , 2015, International journal of cancer.

[20]  Guihua Sun,et al.  MicroRNA-486 regulates normal erythropoiesis and enhances growth and modulates drug response in CML progenitors. , 2015, Blood.

[21]  Hong Yuan,et al.  PLAGL2 regulates actin cytoskeletal architecture and cell migration. , 2014, Carcinogenesis.

[22]  P. Gao,et al.  The role of pleomorphic adenoma gene-like 2 in gastrointestinal cancer development, progression, and prognosis. , 2014, International journal of clinical and experimental pathology.

[23]  X Wang,et al.  Downregulation of miR-486-5p contributes to tumor progression and metastasis by targeting protumorigenic ARHGAP5 in lung cancer , 2014, Oncogene.

[24]  F. Sánchez‐Madrid,et al.  Sumoylated hnRNPA2B1 controls the sorting of miRNAs into exosomes through binding to specific motifs , 2013, Nature Communications.

[25]  Jianming Xu,et al.  Randomized controlled trial of cetuximab plus chemotherapy for patients with KRAS wild-type unresectable colorectal liver-limited metastases. , 2013, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[26]  Yanlei Ma,et al.  SP1 mediates the link between methylation of the tumour suppressor miR‐149 and outcome in colorectal cancer , 2013, The Journal of pathology.

[27]  Meng-Chun W. Yang,et al.  Pleiomorphic adenoma gene-like 2 expression is associated with the development of lung adenocarcinoma and emphysema. , 2011, Lung cancer.

[28]  L. Castilla,et al.  The PlagL2 transcription factor activates Mpl transcription and signaling in hematopoietic progenitor and leukemia cells , 2010, Leukemia.

[29]  Yonghong Xiao,et al.  PLAGL2 regulates Wnt signaling to impede differentiation in neural stem cells and gliomas. , 2010, Cancer cell.

[30]  Tracey S. Hanks,et al.  Modulation of PLAGL2 transactivation by positive cofactor 2 (PC2), a component of the ARC/Mediator complex. , 2010, Gene.

[31]  C. Burge,et al.  Most mammalian mRNAs are conserved targets of microRNAs. , 2008, Genome research.

[32]  B. Wolpin,et al.  Systemic treatment of colorectal cancer. , 2008, Gastroenterology.

[33]  Yuhong Guo,et al.  PLAGL2 translocation and SP-C promoter activity--a cellular response of lung cells to hypoxia. , 2007, Biochemical and biophysical research communications.

[34]  Yu-Chung Yang,et al.  Sumoylation and Acetylation Play Opposite Roles in the Transactivation of PLAG1 and PLAGL2* , 2005, Journal of Biological Chemistry.

[35]  Ruud Delwel,et al.  Plag1 and Plagl2 are oncogenes that induce acute myeloid leukemia in cooperation with Cbfb-MYH11. , 2005, Blood.

[36]  Eugene Berezikov,et al.  Phylogenetic Shadowing and Computational Identification of Human microRNA Genes , 2005, Cell.

[37]  O. Kronborg,et al.  Randomized study of biennial screening with a faecal occult blood test: results after nine screening rounds , 2004, Scandinavian journal of gastroenterology.

[38]  W. V. D. Van de Ven,et al.  The tumorigenic diversity of the three PLAG family members is associated with different DNA binding capacities. , 2002, Cancer research.

[39]  Taiho Kambe,et al.  Involvement of PLAGL2 in activation of iron deficient- and hypoxia-induced gene expression in mouse cell lines , 2001, Oncogene.

[40]  M. Štimpfel,et al.  Cancer incidence and mortality worldwide: sources, methods and major patterns in GLOBOCAN 2012 , 2016 .

[41]  J. Hardcastle,et al.  Colorectal cancer , 1993, Europe Against Cancer European Commission Series for General Practitioners.